Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy. [electronic resource]
Producer: 20120306Description: 299-306 p. digitalISSN:- 1873-5835
- Antigens, CD34 -- metabolism
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Agents -- pharmacology
- Antineoplastic Agents, Hormonal -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Asparaginase -- pharmacology
- Biomarkers, Tumor -- genetics
- Bone Marrow Cells -- drug effects
- Case-Control Studies
- Cell Communication -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Child
- Cohort Studies
- Cytarabine -- pharmacology
- Dexamethasone -- pharmacology
- Gene Expression Profiling
- Humans
- Neoplasm Staging
- Oligonucleotide Array Sequence Analysis
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Principal Component Analysis
- Prognosis
- RNA, Messenger -- genetics
- Real-Time Polymerase Chain Reaction
- Stromal Cells -- drug effects
- Vincristine -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.